(Q37732524)

22 August 2017

1 reference

title

Chemotherapy of chronic haematological malignancies (English)

1 reference

22 August 2017

1 reference

Ho AD

1

1 reference

22 August 2017

1 January 1991

1 reference

Best Practice and Research: Clinical Haematology

22 August 2017

1 reference

22 August 2017

4

1 reference

22 August 2017

1

1 reference

22 August 2017

197-221

1 reference

Prolonged effect of alpha-interferon after discontinuance of treatment in chronic myelogenous leukemia patients

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Clinical course of retrovirus-associated adult T-cell lymphoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Interferon alpha in the treatment of hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Current approaches to the chemotherapy of B-cell chronic lymphocytic leukemia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Clinical trials in hairy cell leukemia. Current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Chronic myelogenous leukemia: is aggressive treatment indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

CHLORAMBUCIL THERAPY FOR LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Long-term interferon therapy for thrombocytosis in myeloproliferative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Collection, Cryopreservation and Subsequent Viability of Haemopoietic Stem Cells Intended for Treatment of Chronic Granulocytic Leukaemia in Blast-Cell Transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Pentostatin in hairy cell leukemia: treatment by the special exception mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Low-dose deoxycoformycin in lymphoid malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Essential thrombocythemia. Clinical characteristics and course of 61 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Results of a prospective randomized trial of early splenectomy in chronic myeloid leukemia. The italian cooperative study group on chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy. A Southeastern Cancer Study Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Hydroxyurea therapy in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Proceedings: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Efficacy of doxorubicin in prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

The treatment of chronic lymphocytic leukemia with COP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Annotation. Myelofibrosis: prognostic factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Randomized trial of splenectomy in Ph1-positive chronic granulocytic leukaemia, including an analysis of prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Clinical course and survival after elective splenectomy in 19 patients with primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Alpha interferon for induction of remission in hairy-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Treatment of hairy cell leukemia with alpha interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Prognostic variables in hairy cell leukemia after splenectomy as initial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Anagrelide: A New Drug for Treating Thrombocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Multiple-drug chemotherapy for acute leukemia.The TRAMPCOL regimen: Results in 86 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Prolymphocytic leukemia: treatment with combination chemotherapy to include doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

Management of CLL and allied disorders with reference to their immunology and proliferation kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980291-4

7 January 2021

10.1016/S0950-3536(05)80291-4

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

2039859